Annual D&A
$69.54M$42.23M-37.79%
Summary
- Current Value
- As of today, GDRX annual D&A is $69.54M, down -37.79% on
- Historical Performance
- GDRX annual D&A is up +84.74% over the past 3 years, and up +342.27% over the past 5 years
- All-Time High Comparison
- GDRX annual D&A is currently -37.79% below its historical high of $111.77M set on
- 3-Year Low Comparison
- GDRX annual D&A is +20.88% above its 3-year low of $57.53M reached on an earlier date
- Sector Comparison
- GDRX annual D&A is higher than 86.54% of companies in Healthcare sector
Depreciation & Amortization Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual D&A | $69.54M | -37.8% | +84.7% | +342.3% | – | |
| Quarterly D&A | $21.43M | +22.2% | +45.2% | +237.0% | – | |
| TTM D&A | $81.17M | -17.3% | +55.3% | +433.1% | – | |
| Price | $2.85 | -35.4% | -41.1% | -93.2% | – | |
| Annual SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Annual Total Expenses | $775.93M | +2.2% | +0.7% | +124.4% | +624.1% | |
| Annual Operating Expenses | $585.28M | +10.7% | -8.0% | +167.5% | +734.4% | |
| Annual Revenue | $792.32M | +5.6% | +6.3% | +104.1% | +697.3% |
Depreciation & Amortization Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $111.77M | -37.8% | |
| 5Y | $111.77M | -37.8% | |
| All | $111.77M | -37.8% |
Depreciation & Amortization Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $57.53M | N/A | +20.9% |
| 5Y | $22.91M | N/A | +203.6% |
| All | $9.81M | +609.1% |
Depreciation & Amortization History
| Year | Value | Change |
|---|---|---|
| $69.54M | -37.8% | |
| $111.77M | +94.3% | |
| $57.53M | +52.8% | |
| $37.64M | +64.3% |
| Year | Value | Change |
|---|---|---|
| $22.91M | +45.7% | |
| $15.72M | +60.3% | |
| $9.81M | - |
FAQ
What is the current annual D&A of GDRX?
As of today, GDRX annual D&A is $69.54M
What is 1-year change in GDRX annual D&A?
GDRX annual D&A is down -37.79% year-over-year
What is 3-year change in GDRX annual D&A?
GDRX annual D&A is up +84.74% over the past 3 years
How far is GDRX annual D&A from its all-time high?
GDRX annual D&A is currently -37.79% below its historical high of $111.77M set on December 31, 2023
How does GDRX annual D&A rank versus sector peers?
GDRX annual D&A is higher than 86.54% of companies in Healthcare sector
When is GDRX next annual earnings release?
The next annual earnings release for GDRX is on
Quarterly D&A
$21.43M$1.70M+8.63%
Summary
- Current Value
- As of today, GDRX quarterly D&A is $21.43M, up +8.63% on
- Historical Performance
- GDRX quarterly D&A is up +22.22% year-over-year, and up +45.23% over the past 3 years
- All-Time High Comparison
- GDRX quarterly D&A is currently -55.08% below its historical high of $47.71M set on
- 3-Year Low Comparison
- GDRX quarterly D&A is +34.43% above its 3-year low of $15.94M reached on
- Sector Comparison
- GDRX quarterly D&A is higher than 86.67% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly D&A | $21.43M | +8.6% | +22.2% | +45.2% | +237.0% | |
| Annual D&A | $69.54M | – | -37.8% | +84.7% | +342.3% | |
| TTM D&A | $81.17M | +5.0% | -17.3% | +55.3% | +433.1% | |
| Price | $2.85 | -35.1% | -35.4% | -41.1% | -93.2% | |
| Quarterly SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Quarterly Total Expenses | $194.91M | +2.5% | +1.9% | -14.9% | +2.3% | |
| Quarterly Operating Expenses | $134.76M | -5.3% | -7.4% | -11.9% | -27.9% | |
| Quarterly Revenue | $196.03M | -3.5% | +0.4% | +4.7% | +39.6% |
Quarterly D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $21.43M | at high | |
| 3Y | $47.71M | -55.1% | |
| 5Y | $47.71M | -55.1% | |
| All | $47.71M | -55.1% |
Quarterly D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $19.10M | N/A | +12.2% |
| 3Y | $15.94M | +34.4% | |
| 5Y | $5.45M | N/A | +293.2% |
| All | $4.35M | +393.2% |
Quarterly D&A History
FAQ
What is the current quarterly D&A of GDRX?
As of today, GDRX quarterly D&A is $21.43M
What is GDRX quarterly D&A most recent change?
GDRX quarterly D&A was up +8.63% on September 30, 2025
What is 1-year change in GDRX quarterly D&A?
GDRX quarterly D&A is up +22.22% year-over-year
How far is GDRX quarterly D&A from its all-time high?
GDRX quarterly D&A is currently -55.08% below its historical high of $47.71M set on December 31, 2023
How does GDRX quarterly D&A rank versus sector peers?
GDRX quarterly D&A is higher than 86.67% of companies in Healthcare sector
When is GDRX next earnings release?
The next earnings release for GDRX is on
TTM D&A
$81.17M$3.90M+5.04%
Summary
- Current Value
- As of today, GDRX TTM D&A is $81.17M, up +5.04% on
- Historical Performance
- GDRX TTM D&A is down -17.31% year-over-year, and up +55.32% over the past 3 years
- All-Time High Comparison
- GDRX TTM D&A is currently -27.38% below its historical high of $111.77M set on
- 3-Year Low Comparison
- GDRX TTM D&A is +41.10% above its 3-year low of $57.53M reached on an earlier date
- Sector Comparison
- GDRX TTM D&A is higher than 85.99% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM D&A | $81.17M | +5.0% | -17.3% | +55.3% | +433.1% | |
| Annual D&A | $69.54M | – | -37.8% | +84.7% | +342.3% | |
| Quarterly D&A | $21.43M | +8.6% | +22.2% | +45.2% | +237.0% | |
| Price | $2.85 | -35.1% | -35.4% | -41.1% | -93.2% | |
| TTM SG&A | -$5.70B | -1339.3% | -1260.0% | -1173.0% | -1685.6% | |
| TTM Revenue | $800.65M | +0.1% | +1.3% | +0.6% | +56.9% |
TTM D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $81.17M | at high | |
| 3Y | $111.77M | -27.4% | |
| 5Y | $111.77M | -27.4% | |
| All | $111.77M | -27.4% |
TTM D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $69.54M | N/A | +16.7% |
| 3Y | $57.53M | N/A | +41.1% |
| 5Y | $20.68M | N/A | +292.6% |
| All | $4.35M | +1768.1% |
TTM D&A History
FAQ
What is the current TTM D&A of GDRX?
As of today, GDRX TTM D&A is $81.17M
What is GDRX TTM D&A most recent change?
GDRX TTM D&A was up +5.04% on September 30, 2025
What is 1-year change in GDRX TTM D&A?
GDRX TTM D&A is down -17.31% year-over-year
How far is GDRX TTM D&A from its all-time high?
GDRX TTM D&A is currently -27.38% below its historical high of $111.77M set on December 31, 2023
How does GDRX TTM D&A rank versus sector peers?
GDRX TTM D&A is higher than 85.99% of companies in Healthcare sector
When is GDRX next earnings release?
The next earnings release for GDRX is on
Data Sources & References
- GDRX Official Website www.goodrx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1809519/000180951925000143/0001809519-25-000143-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1809519/000180951925000040/0001809519-25-000040-index.htm
- GDRX Profile on Yahoo Finance finance.yahoo.com/quote/GDRX
- GDRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gdrx